BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15894357)

  • 1. Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women.
    Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
    Gynecol Oncol; 2005 Jul; 98(1):63-7. PubMed ID: 15894357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
    Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.
    Garuti G; Cellani F; Centinaio G; Montanari G; Nalli G; Luerti M
    Gynecol Oncol; 2006 Nov; 103(2):599-603. PubMed ID: 16750259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?
    Garuti G; Grossi F; Cellani F; Centinaio G; Colonnelli M; Luerti M
    Breast Cancer Res Treat; 2002 Apr; 72(3):245-53. PubMed ID: 12058966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor-positive breast cancer.
    López DM; Fernández YG; Sánchez AV; Alvarez MI; Reynaldo MI; Delgado RC
    Menopause; 2013 Jan; 20(1):64-71. PubMed ID: 22968254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
    Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
    Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
    J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer.
    Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M
    J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR;
    Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
    BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen.
    Liedman R; Lindahl B; Andolf E; Willen R; Ingvar C; Ranstam J
    Anticancer Res; 2000; 20(6C):4889-91. PubMed ID: 11205237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
    Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
    Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
    Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
    Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
    Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
    Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
    Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
    Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
    Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
    Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
    Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial effects of exemestane compared to tamoxifen within the Tamoxifen Exemestane Adjuvant Multicenter (TEAM) trial: results of a prospective gynecological ultrasound substudy.
    Kieback DG; Harbeck N; Bauer W; Hadji P; Weyer G; Menschik T; Hasenburg A
    Gynecol Oncol; 2010 Dec; 119(3):500-5. PubMed ID: 20832103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uterine abnormalities in non menopausal women who received tamoxifen for breast cancer adjuvant therapy].
    d'Arailh AS; Michy T; Pioud R; Dravet F; Classe JM
    Gynecol Obstet Fertil; 2007 Dec; 35(12):1215-9. PubMed ID: 18035581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.